Investors yawn at latest Citron jab, send Intuitive Surgical shares up

February 21, 2013 by MassDevice staff

Investors ignore a 3rd negative report from short-seller Citron Research on medical device company Intuitive Surgical, sending shares up slightly today.

Intuitive Surgical

Investors, who sent shares of Intuitive Surgical (NSDQ:ISRG) down 10% the 1st time Citron Research issued a negative report on the medical device company, yawned today at a 3rd missive from the short seller.

ISRG shares were up slightly as of about 3:30 p.m. today to $561.07 apiece, despite Citron's repeated assertion that the stock is headed for $300 per share.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.